Given the significant blocking effects of HS14 and dHG-5 on platelet TLR2, these compounds may possess considerable potential for therapeutic applications in conditions such as sepsis, atherosclerosis, and rheumatoid arthritis. Here, TLR2 is linked to Sepsis.